Back My treatment worked and there is little or no cancer left No cancer after first line chemo Answer each question to find trials that best match your clinical situation. You can leave questions blank if you do not know the answer. This search will output a list of trials for which you may be eligible based on the criteria you enter. I want to enter information about my cancer and treatments I want to enter information about my genetic testing (e.g, BRCA) and/or tumor testing results I want to filter the trials based on location, phase of development, tumor genomic alteration, or drug name, category or target Phase: selectPhase 1Phase 1 with expansionPhase 1 with ovarian expansionPhase 2Phase 3 Drug Category: selectAngiogenesis InhibitorsAntibody Drug ConjugatesApoptosis InducersB-cell antigen receptor (BCR) Signaling Pathway InhibitorsCell Cycle InhibitorsChemotherapyChromatin Structure/Gene Expression RegulatorsDNA Damage Repair Pathway Inhibitors: ATM, ATR, DNA-PK, etcDNA Damage Repair Pathway Inhibitors: PARPGene TherapyGrowth Factor InhibitorsGrowth Factor Receptor InhibitorsHormonal TherapyImmunotherapy: Anti-Tumor AntibodiesImmunotherapy: BispecificsImmunotherapy: Cellular TherapyImmunotherapy: Checkpoint InhibitorsImmunotherapy: Immune Cell StimulatorsImmunotherapy: ImmunomodulatorsImmunotherapy: VaccinesOncolytic VirusesRadiotherapy: RadiationRadiotherapy: RadioimmunoconjugatesSignaling Pathway Inhibitors: HedgehogSignaling Pathway Inhibitors: Integrins-FAKSignaling Pathway Inhibitors: JAK-STATSignaling Pathway Inhibitors: NotchSignaling Pathway Inhibitors: PI3K-AKT-mTORSignaling Pathway Inhibitors: RAS-RAF-MEK-ERKSignaling Pathway Inhibitors: TGF-betaSignaling Pathway Inhibitors: WNT/Beta-catenin Drug Name: No preference No preference[225Ac]-FPI-1434153-Sm-DOTMP177Lu-FAP-228623ME-00610A2B530AB-1015AB248AB598ABBV-CLS-484ABBV-CLS-579AbemaciclibAbexinostatABL503ABM-1310ABM-168ABSK061ABSK121ACR-368ADA-011AdagrasibADCT-901ADG106ADG116ADG126ADP-A2M4CD8ADU-1805AG01AGEN1571AGEN2373agenT-797AGX148AGX148/PH-762AldesleukinAlectinibALG.APV-527AlpelisibAlpha-DC1 vaccineAMG 193AMG 404AMXI-5001AMXT 1501AN4005Anastrozoleanti-EGFR AbAnti-KRAS G12D mTCR PBLAnti-KRAS G12V mTCR PBLAOH1996ART0380ART6043ASCA101AsiDNAASKG915ASN004ASP1570ASP3082ASTX029ASTX727AtezolizumabATG-101ATLCAR.CD30ATRN-119AU-007AU-409Autologous nCTLsAutologous TILsAvapritinibAVB-001AvutometinibAxatilimabAxitinibAza-TdCAZD1390AZD5305AZD5335AZD8205AZD9574AzeliragonAzenosertibBAL0891BalstilimabBAY2416964BAY2965501BAY3375968BB-1701BBI-355BBP-398BDC-1001BDTX-4933BelinostatBelvarafenibBemarituzumabBerzosertibBevacizumabBGB-15025BGB-24714BGB-30813BGB-A425BGB-B167BI 1703880BI 765179BI 907828BI-1206BinimetinibBintrafusp alfaBIO-106BirinapantBJ-001BJ-005BLU-222BMS-986288BMS-986406BMS-986408BMS-986442BMS-986449BNT142BNT151BNT152BNT153BortezomibBotensilimabBozitinibBrimarafenibBT4780BT5528BT8009BTX-A51BuparlisibBusulfanCAB-CTLA-4CabozantinibCamizestrantCamonsertibCAN1012CapecitabineCAR.B7-H3CarboplatinCBX-12CDX-1140CDX-585CediranibCemiplimabCeralasertibCetuximabCF33-hNISCFI-402411CFT1946CFT8634CHS-006CisplatinCLN-418CLN-619ClofarabineClostridium Novyi-NTCM24CobimetinibColchicineCOM701COM902CopanlisibCPO-100CrizotinibCRX100CS5001CT-0508CTX-471CUE-102CYC140CyclophosphamideD-1553D3S-001DasatinibDatopotamab deruxtecanDB-1305DB-1310DCBY02DCC-3116DCSZ11DDRiDebio 0123DECOY20DefactinibDenileukin diftitoxDevimistatDF1001DF6002DF9001Disitamab vedotinDivarasibDK210 (EGFR)DocetaxelDostarlimabDovitinibDoxorubicinDS-1103aDS-3939aDS-9606aDurvalumabDZ-002E7046Efineptakin alfaEflornithineELI-002 7PElimusertibELU001EMB-02EncorafenibEnfortumab VedotinEnoblituzumabEntinostatEntrectinibEO-3021EOS-448EP0031ERAS-601EribulinErlotinibEtigilimabEtoposideEU101EverolimusEvorpaceptExarafenibEzabenlimabFadraciclibFarletuzumab ecteribulinFF-10850 Topotecan LiposomeFludarabineFOG-001FS120FSHCER T cellsFT538FulvestrantFutibatinibFX-909Gavocabtagene autoleucelGDC-1971GedatolisibGemcitabineGEN1047GEN1053GI-101GI-102GiredestrantGotistobartGS-1811GS-9716GSK4381562GSK6097608GunagratinibGV20-0251HB0025HB0036HCW9218HH2853HIPECHMBD-002HST-1011hSTC810huCART-meso cellsHuMax-IL8HydroxychloroquineIACS-6274IBI322IcatolimabICT01IDE161IDE397IGM-8444Igrelimogene litadenorepvecIK-930IL-12IMA203IMA203CD8IMC-F106CIMGN151IMGS-001IMM-1-104IMNN-001IMP7068IMP9064IMSA101InavolisibINBRX-105INBRX-106INCB099280INCB123667Individual Patient TCR-Transduced PBLInupadenantINV-1120INX-315IO-108IO-202IpatasertibIPG7236IpilimumabIrinotecanISM3091IvosidenibIVS-3001JAB-21822JAB-2485JAB-3312JAB-8263JBI-802JDQ443JPZ815JZP341KB-0742KD033KFA115KIN-3248KT-253KT-333KVA12123KZR-261Labvax 3(22)-23LapatinibLarotrectinibLBL-007LenvatinibLetrozoleLifirafenibLiposomal doxorubicinLisaftoclaxLM-108LMB-100LNS8801LorigerlimabLorlatinibLOXO-435LP-184LunresertibLuveltamab tazevibulinLVGN3616LVGN6051LVGN7409LY3295668LY3537982LYT-200MaplirpaceptM-CENKMCLA-145MDK-703MDNA11Mecbotamab VedotinMetarrestinMetforminMethoxyamineMinnelideMinoxidilMirdametinibMirvetuximab soravtansineMK-0472MK-1084MK-1484MK-4464MK-4830MK-6598MOv19-BBz CAR TMRG002MRG004AMRT-2359MRTX0902MRTX1133MRTX1719MT-6402MT-8421MTB-9655MV-NIS infected mesynchymal stem cellsnab-PaclitaxelNab-Paclitaxel/STI-3031nab-SirolimusNanrilkefusp alfaNaporafenibNavicixizumabNB003NBTXR3NC410NC762NDI-101150NedisertibNelfinavir mesylateNemvaleukin alfaNeoVaxNeratinibNerofeNG-350ANG-641NGM438NGM707NGM831NilotinibNiraparibNivolumabNM1FNM21-1480NMS-03305293Nogapendekin alfaNP-G2-044NT-175NT219NTX-1088NUV-868NVL-520NVL-655NX-019NX-1607NXP800NY-ESO-1 Peptide vaccineNY-ESO-1 TCR transgenic T cells and NY-ESO-1 TCR/sr39TK transgenic stem cellsOBI-3424OBI-999OBT076OKI-179OlaparibOlvimulogene nanivacirepvecOMTX705ON 123300ONC201OR2805ORB-011ORIC-114OTX-2002OxaliplatinOzuriftamab VedotinPaclitaxelPaclitaxel-loaded TPMPalbociclibPamiparibPaxalisibPazopanibPBI-200PC14586PD-1iPD-L1iPegcetacoplanPelcitoclaxPembrolizumabPemetrexedPertuzumabPF-07104091PF-07220060PF-07284892PF-07799544PF-07799933PHESGOPidnarulexPimasertibPimicotinibpING-hHER3FLPIPACPlixorafenibP-MUC1C-ALLO1 CAR-T cellsPralsetinibPrexigebersen-APRGN-3005PRGN-3007ProAgioPRT3789PRTH-101PT199PUR001PYX-201Q702Q901Radiation TherapyRaludotatug deruxtecanRBN-2397RBS2418REGN5668REGN7075RegorafanibRelacorilantRelatlimabRepotrectinibrhIL-15RibociclibRiMO-301Rinatabart sesutecanRintatolimodRLY-2608RLY-4008RLY-5836RMC-4630RMC-5552RMC-6236RMC-6291RMC-9805RNK05047RO7515629RP1RP3RSC-1255RunimotamabRX108S095029Sacituzumab govitecanSAR444200SAR444245SB 11285Selected Young TILSelpercatinibSelumetinibSenaparibSerabelisibSGN1SGN-ALPVSGN-TGTSHetA2siRNA-EphA2-DOPCSirolimusSKL27969SL-172154SLC-3010Sleeping Beauty Transposed PBLSNK02SNS-101SON-1010SON-DPSotorasibSRF114SRK-181ST-067ST316STAR0602STC-15StenoparibSTI-6643STK-012STP707STX-478Sudocetaxel zendusortideSunitinibSurgerySym021SynKIR-110T3011TAC-001TAC01-CLDN18.2TACH101TAEK-VAC-HerByTAG72-CAR T cellsTaladegibTalazoparibTAS0953/HM06TAVO412TazemetostatTBX-3400TC-510TemozolomideTemsirolimusTemuterkibThermotherapyTiragolumabTislelizumabTivozanibTJ-CD4BTNG260TNG462TNG908TNO155TopotecanToripalimabTORL-1-23TORL-2-307-ADCTOS-358TovorafenibTrametinibTransCon IL-2 β/γTransCon TLR7/8TrastuzumabTrastuzumab deruxtecanTrastuzumab emtansineTRE-515TremelimumabTRK-950TST003TTfieldsTU2218TucatinibTulmimetostatTuvusertibTY-2136bTYRA-300UbamatamabUCT-01-097UCT-03-008Valproic acidVB10.NEOVCN-01VEGFR TKIVemurafenibVenetoclaxVinorelbineVIP236VismodegibVMD-928Vobramitamab duocarmazineVT3989VudalimabWTX-124WTX-330XB002XL092XL102XmAb24306XmAb662XmAb808XMT-1660XTX101XTX202XTX301YL-13027ZafirlukastZanidatamabZeaxanthinZEN-3694ZenocutuzumabZimberelimabZL-1218ZX-4081 Location: selectAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming Molecular Target: No preference No preference4-1BB (CD137)5T4 oncofetal AgA2aRA2RACSS2 (Acetyl-CoA Synthetase 2)AHR (aryl hydrocarbon receptor)AktAKT1-3ALKALPG/P (alkaline phosphatase germ-line/placental)Alpha v beta 3Alpha v beta3,5,6Alpha-V/Beta-3 integrinALPP (Alkaline phosphatase, placental)AMPKARAFARK5AromataseAsparagineATMATRAURKAURKAAxlB7H3B7H4BclBcl-2BCL9/beta-catenin AntagonistBcl-XLbcr-ablBETBRAFBRD4BRD9BTLA (CD272)BTN1A1BTN3A (CD277)C3CA125CAPRIN-1CBL-BCCR1CCR5CCR8CD163CD200R1CD205CD22CD27CD28CD3CD30CD32BCD39CD40CD47CD73CD8CD93CD96CDH6CDKCDK2CDK2/5/9CDK4CDK4/6CDK5CDK7CDK9CEACEACAM1 (CD66a)CEACAM5 (CD66e)ChkChk1CHK1/2CK1alphac-KitCLDN18.2 (Claudin 18.2)CLDN6 (Claudin 6)c-MetCoRESTCOX-2CRAFCSF1R (fms)CTLACTLA-4CXCRCXCR3CYSLTR1 (cysteinyl leukotriene 1 receptor)dCK (deoxycytidine kinase)DCKzeta (diacylglycerol kinase zeta)DDR1 (Discoidin Domain Receptor 1)DGKzetaDHFR (Dihydrofolate reductase)DLL4DNADNA polymerase alphaDNA polymerase theta (POLQ)DNA-PKDNMT (DNA methyltransferase)EDB (Extra Domain B of fibronectin)eEF2 (Eukaryotic Elongation Factor 2)EF-2 (Elongation Factor 2)EGFREGFR (kinase)ENPP1EP4 (prostaglandin E2 receptor subtype 4)EphA2ERERBB3(HER3)ERKERK1/2EZH1EZH1/2EZH2FAKFAP (fibroblast activation protein alpha)FAPalphaFASFascinFcγRIII (CD16)FGFRFGFR1FGFR1,3FGFR1-4FGFR2FGFR2,3FGFR2bFGFR3FGFR4FKBP-12FLT3FRalphaFSHR (Follicle Stimulating Hormone Receptor)Galectin-9Globo H (globohexaosylceramide)GlutaminaseGPC3 (Glypican 3)GPER (G protein-coupled estrogen receptor)GRGrb2GREM1 (Gremlin1)Grp78GSPT1HDAC (Histone deacetylase)HDAC6 (histone deacetylase 6)HER2HER2 (kinase)HER4HIV proteaseHLA-GHPK1 (hematopoietic progenitor kinase I)HRASHsc70HSF1 pathwayHsp70IAPIDH1IFNR alphaIGF-1RIGSF8IL-10RIL-12RIL-15RIL-18RIL-2RIL-2R alphaIL-2R betaIL-2R/IL-15R beta/gammaIL-7RIL-8ILT2ILT3ILT4IRS1/2ItkKAAG1KDM4Kir6/SUR2 channelKRASLabyrinthinLAG-3 (lymphocyte activation gene-3)LAIR-1 (CD305)latent TGFbeta1LckLILRBLSD1LysosomeMAGE-A4MAT2A (methionine adenosyltransferase 2A)MCL1MDMMDM2MEKMEK1MEK1/2MerMesothelinMethionineMETTL3MICAMICA/B (MHC class I chain-related protein A and B)MICBMitochondrial Hsp70MPS1 (TTK)mTORMUC16 (CA125)MUC1-CMYCNectin-4NeoantigensNF-kappaBNKG2ANOS (Nitric oxide synthase)NRASNTRK (Trk)NTRK1 (TrkA)NTRK1-3 (TrkA-C)NTRK2 (TrkB)NTRK3 (TrkC)NY-ESO-1ODC (ornithine decarboxylase)OX40p53_ap53_gpan-PI3KPARGPARPPARP1PARP1/2PARP7PCNAPD-1PDGFRPDGFR3PDGFRaPDGFRbPD-L1PD-L2PGRN/GP88 (Progranulin)PI3KPI3K alphaPI3K betaPI3K gammaPI3K/mTORPKMYT1PLK-1Pol I (RNA polymerase I)Polyamine TransportPPAR gammaPRAMEPRMT5proteasome-20SPTPN2PVRPVRIGRAFRAGERASRETRibosomeROR1ROR2ROSROS1RRM1(Ribonucleotide reductase)Sec61SHP2SIRPalpha (CD172a)SMARCA2SmoothenedSodium Potassium PumpSORT1SOS1SRCSRC family kinasesST2 (IL1RL1)STAT3STINGTACTILETAG72 (tumor-associated glycoprotein 72)TA-MUC1Tankyrase 1/2TCF/beta-cateninTCR Vb6/Vb10TEADTGFbetaTGFbeta1TGFbetaR1TIE-2TIGITTIM-3Tissue FactorTLRTLR3TLR7TLR7/8TLR8TLR9TNFalphaTOPO ITOPO II (TOP2A)TORCTORC1TRAILR2 (DR5)TROP2 [EGP-1 (epithelial glycoprotein-1)]TS (Thymidylate synthase)TubulinTumor Associated AntigensULKULK1ULK1/2ULK2UndisclosedUSP1 (ubiquitin-specific protease inhibitor 1)VEGFVEGFRVEGFR1,2,3VEGFR2VEGFR2/3VISTAWEE1WT1 Other Common Drug Names: No preference No preference14-Hydroxydaunomycin2-difluoromethylornithine hydrochloride2-F-ara-AMP2X-1215-aza-4'-Thio-2'-Deoxycytidine8394A genetically modified oncolytic viral strain of the herpes simplex type 1 (HSV-1) virusA humanized anti-B7-H3 antibody conjugated to the vc- seco - DUocarmycin-hydroxyBenzamide-Azaindole (DUBA) 2 DNA alkylating payloadA2A receptor antagonist EOS100850AB122ABI-007ABI-009Abiplatin ABL111AbraxaneABSK021ABT-0199AccolateACT50Ad5/3-E2F-d24-hTNFa-IRES-hIL2ADC DS-8201aado trastuzumab emtansineAF802AfinitorAG-013736AG-120AGEN1181AGEN1777AGEN2034AK-01AKR1C3-activated prodrug OBI-3424Akt Inhibitor GDC-0068AKT/ERK inhibitor ONC201AlecensaAlimtaALK inhibitor CH5424802ALK/ROS1/NTRK/SRC multi-kinase inhibitor TPX-0005ALKS4230Allogeneic NK cellsalpha-lipoic acid analogue CPI-613ALT-803ALX148AMG 510AMN 107AMX513 dicaprateAN0025AN2025anaplastic lymphoma kinase inhibitor CH5424802ANB011Anti-B7H1 Monoclonal Antibody MEDI4736anti-CCR8 monoclonal antibody LM-108anti-CD137 agonistic monoclonal antibody ADG106anti-CD137 agonistic monoclonal antibody LVGN6051anti-CD205 antibody-drug conjugate OBT076anti-CD27 monoclonal antibody GEN1053/BNT313anti-CD32B monoclonal antibody BI-1206anti-CD96 monoclonal antibody GSK6097608anti-CEA/Anti-4-1BB bispecific antibody BGB-B167anti-cMET/EGFR/VEGF trispecific antibody TAVO412anti-CTLA4 human monoclonal antibody CP-675,206anti-CTLA-4 monoclonal antibody ADG126anti-CTLA-4 monoclonal antibody AGEN1181anti-CTLA-4 probody BMS-986288anti-CTLA-4 SAFEbody ADG126Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibodyanti-DLL4/VEGF bispecific monoclonal antibody OMP-305B83Anti-EGFR Monoclonal AntibodyAnti-erbB2 Monoclonal Antibodyanti-FGFR2 monoclonal antibody FPA144anti-folate receptor-alpha antibody drug conjugate STRO-002Anti-FOLR1-mab Maytansinoid Conjugateanti-FRa antibody-drug conjugate AZD5335anti-globo H/MMAE antibody-drug conjugate OBI 999anti-HER2 ADC DS-8201aanti-HER2 ADC RC48anti-HER2 antibody-drug conjugate DS-8201aanti-HER2 bi-specific monoclonal antibody ZW25anti-HER2 CAR macrophagesanti-HER2 x anti-CD3 bispecific monoclonal antibody BTRC 4017Aanti-HER2/Anti-HER3 bispecific monoclonal antibody MCLA-128anti-hFcγRIIB monoclonal antibody BI-1206anti-IL-8 monoclonal antibody HuMax-IL8anti-ILT2/anti-ILT4 monoclonal antibody NGM707anti-ILT4 monoclonal antibody MK-4830Anti-LAG-3 monoclonal antibody BMS-986016anti-LAG-3 monoclonal antibody LBL-007anti-latent TGF-beta 1 monoclonal antibody SRK-181anti-LILRB monoclonal antibody ADA-011anti-LILRB4 monoclonal antibody IO-202anti-mesothelin cytolytic fusion protein LMB-100anti-mesothelin recombinant cytolytic fusion protein RO6927005anti-MUC16/CD3 bispecific antibody REGN4018Anti-PD-1 human mab MDX-1106anti-PD-1 monoclonal antibody AB122anti-PD1 monoclonal antibody AGEN2034anti-PD-1 monoclonal antibody AMG 404anti-PD-1 monoclonal antibody BGB-A317anti-PD-1 monoclonal antibody BI 754091anti-PD-1 monoclonal antibody REGN2810anti-PD-1 monoclonal antibody TSR-042anti-PD-1/anti-CTLA-4 DART protein MGD019anti-PD1/CTLA4 bispecific antibody XmAb20717Anti-PD-L1 Monoclonal Antibody MPDL3280A anti-PD-L1/4-1BB bispecific antibody ATG-101anti-PD-L1/4-1BB bispecific antibody INBRX-105anti-PD-L1/anti-4-1BB bispecific antibody ABL503anti-PVR monoclonal antibody NTX-1088anti-TCR Vb6/Vb10/IL-2 antibody fusion protein STAR0602anti-TIGIT monoclonal antibody SGN-TGTanti-TIGIT monoclonal antibody TAB006anti-TIGIT OMP-313M32anti-TROP-2 Antibody-Drug Conjugate IMMU-132Anti-TROP2/DXd antibody-drug conjugate DS-1062aanti-VEGF monoclonal antibodyAnzataxAP160APG-1252APG-2575APL-101APL-2ArimidexARRY-142886ARRY-162ARRY-438162ARRY-440ARRY-558aryl hydrocarbon receptor antagonist BAY2416964AS703026AsotaxATR kinase inhibitor AZD6738ATR kinase inhibitor BAY1895344ATR kinase inhibitor M1774ATR kinase inhibitor VX-970AtvogenAUR102Aurora A kinase inhibitor JAB-2485autologous aDC1-induced CTLsautologous anti-mesothelin KIR-CAR-transduced T cells SynKIR-110autologous anti-mesothelin T-cell receptor fusion construct T cells TC-210autologous anti-MUC16 CAR-mbIL15-HER1t T cells PRGN-3005autologous CAR-mbIL15-safety switch T cells PRGN-3007autologous CD30CAR-CD28-CD3zeta-expressing T lymphocytesautologous cytokine-induced killer cells/vaccinia virus DD-CDSR CRX100autologous genetically-modified MAGE-A4 C1032 CD8alpha T cellsautologous memory cytokine-enriched natural killer cellsAutologous Natural Killer Cell-like nCTLsautologous natural killer-like cytotoxic lymphocytesautologous PBLs retrovirally-transduced with TCRs targeting neoantigensautologous TBX-4000-treated peripheral blood mononuclear cells TBX-3400autologous TCR-engineered T cells IMA203AV-951AvastinAZD2171AZD2281AZD6244AZD6738B1939 mesylateBA3011BA3021BA3071BAY 80-6946BAY1895344BAY73-4506Bcl-2 inhibitor APG 2575Bcl-2 inhibitor GDC-0199Bcl-2/Bcl-XL inhibitor APG-1252BemaciclibBeneflurBET bromodomain inhibitor ZEN-3694BGB-283BGB-3245BGB-A317BI 754091Biovelbinbispecific CD80-lgG4Fc-IL-2v fusion protein GI-101bispecific CD80-lgG4Fc-IL-2v fusion protein GI-102BKM120Blastolem BLU-667BMN-673BMS-354825BMS-907351BMS-936558BMS986016BMS-986253BNT142 RiboMab (mRNA-encoded antibody)BP1001-ABRAF inhibitor PLX8394BRAF/EGFR inhibitor BGB-283brain-penetrant ATM inhibitor AZD1390BRD4 protein degrader RNK05047Briplatin BristaxolBT5528 - an EphA2-targeting Bicycle Toxin ConjugateBT5528-100BT8009 - a Nectin-4-targeting Bicycle Toxin ConjugateBT8009-100BTRC 4017ABTX A51BusulfexbusulphanBYL719C3-targeted complement inhibitor APL-2CAB-AXL-ADCCabometyxCACPCampothecin-11CamptoCamptosarCAPECarloxanCBL-B inhibitor NX-1607CBT-101CCI-779CD47 antagonist ALX-148CD47/SIRPa-blocking agent ALX148CD4BCDA inhibitor E7727/decitabine combination agent ASTX727CDDPCDK2/5/9 inhibitor CYC065CDK4/6 Dual Inhibitor LY2835219CDK4/6 Inhibitor LEE011Cediranib maleateCerticanCF33-hNIS (hNIS - human sodium iodide symporter)CH5126766checkpoint kinase 1 inhibitor LY2606368Chimeric MoAb C225CiclofosfamidaCiclofosfamideCicloxalcis-DDPcis-platinumCisplatyl Citoplatino Citosin CK1alpha/CDK7/CDK9 inhibitor BTX-A51CKI27ClafenClapheneClofarexClolarClostridium novyi-NT sporesCM-24c-met/HGFR tyrosine kinase inhibitor PF-02341066Cometriqconditionally active biologic anti-AXL antibody-drug conjugate BA3011conditionally active biologic anti-CTLA4 antibody BA3071CORT125134Cotellic CP monohydrateCP-675CP-675,206CP-675206CPI-0209CPI-613CPMCRX-100CX-5461CYC065CycloblastinCycloblastineCYCLO-cellCyclophosphamCyclophosphamid monohydrateCyclophosphamidumCyclophosphanCyclophosphanumCycloSamCyclostinCyclostineCytophosphanCytophosphanecytotoxic lymphocyte maturation factor interleukin-12CytoxanDAB389 interleukin-2 immunotoxinDacotinDacplatDato-DXdDAY101DepaconDepakeneDF8001DFMOdiacylglycerol kinase zeta inhibitor BGB-30813DNA Damage Response InhibitorDNA repair inhibiting oligonucleotideDNA-PK inhibitor MSC2490484ADocetaxel Nanoparticle Formulated with Human AlbuminDoxilDox-SLDS-3939DS-6000aDS-8201DS-8201adual PI3 kinase/mTOR inhibitor PKI-587E7080E7389E7438E7449E7777Edodekin alfaEGEN-001EGFR/HER2 inhibitor ORIC-114EloxatinEloxatineEMD 1036239enadenotucirev-expressing anti-CD40 agonistic monoclonal antibody NG-350enadenotucirev-expressing FAP/CD3 bispecific FAP-TAc NG-641EndoxanEndoxanaEnduxanENV-101EOS-850EP4 antagonist INV-1120epipodophyllotoxinEPZ6438ER-086526ER-203492-00ERAS-254ErbituxErivedgeERK 1/2 inhibitor ASTX029EunadesEvacetEZH2 inhibitor CPI-0209fam-trastuzumab deruxtecan-nxkiFaslodexFemaraFGFR inhibitor TAS-120 Flex-Het SHetA2Fludara OralFollicle Stimulating Hormone Receptor T CellsFORE8394FortametFosfaseronFPA144G protein-coupled estrogen receptor agonist LNS8801GDC-0068GDC-0077GDC-0084GDC-0199GDC-0449GDC-0973GDC-6036GDC-9545GemzarGEN-1GenoxalGL-ONC1GLS-010GlucophageGlumetzaglutaminase inhibitor IPN60090GLV-1h68GSK1120212GSK572016GW2016GX-I7hafnium oxide-containing nanoparticles NBTXR3Halavenhalichrondrin B analogHDAC inhibitor CRA-024781HDAC inhibitor SNDX-275Hedgehog antagonist GDC-0449HER2 Monoclonal AntibodyHER2 tri-specific natural killer cell engager DF1001Herceptinhistone methyl transferase EZH2 inhibitor E7438HKI-272HM95573HOV2hrS7-SN38 antibody drug conjugatehuman interleukin-7 mRNA-encoded BNT152HycamptamineHycamtinHydroxyl-DaunorubicinHyleukinHyperthermic Intraperitoneal ChemotherapyIACS-15509IbranceICI 182,780ICON-2ICP-192IL-15/IL-15 receptor alpha sushi+ domain fusion protein SO-C101IL15/IL15R alpha heterodimeric Fc-fusionsIL-2/Anti-IL-2 antibody conjugate SLC-3010IMC-F106C, a T cell redirecting bi-specific biologicImfinziIMGN853immunoglobulin G1 (human-mouse monoclonal rhuMab-VEGF gamma-chainIMNN-001INBRX-106: Hexavalent OX40 AgonistINK-1117InlytaInterleukin-15 fusion protein BJ-001interleukin-15/interleukin-15 receptor alpha complex-Fc fusion protein XmAb24306interleukin-15/interleukin-15 receptor alpha sushi+ domain fusion protein SO-C101intermediate-affinity interleukin-2 receptor agonist ALKS 4230IPN60090iPSC-derived CD16/IL-15RF-expressing CD38-eliminated NK Cells FT538IrbinitinibIrradiationJS001JS006JTP-74057JTX-1811KadcylaKDM4 inhibitor TACH101KeytrudaKIN-2787KisqaliKoselugoKRAS G12C inhibitor MRTX849KRAS mutant-targeting AMG 510KRAS-MAPK signaling pathway inhibitor JAB-3312LAIR-2 fusion protein NC410Lambrolizumablapatinib ditosylateLastetLederplatin LedoxinaLEE011LenvimaLGX818LibtayoLifirfeniblight-emitting oncolytic vaccinia virus GL-ONC1LipoDoxliposomal doxorubicinLOXO-101LOXO-292LY2606368LY2853219LY2940680LY3214996LynparzaM1774M3814M6620M7824M9346A-sulfo-SPDB-DM4mab MGA271MCLA-128MDL 71782MDV3800MDX 018MDX-010MDX-1106MEDI4736MEK Inhibitor GSK1120212MEK inhibitor MEK162MEK inhibitor PD0325901MEK162MekinistMektoviMEN 1309metal-organic framework (MOF) compound RiMO-301Metaplatin MethazolastoneMGA271MGC018MGD019MitoxanMK3475MK-3475MK4827MK-6018MK-7902ML-246MLN1117MOF compound RiMO-301monoclonal antibody 2C4monoclonal antibody TRK-950MORAb-202MPDL3280AMRTX849MS 275MSB0011359CMSC1936369BMTIG7192Amultikinase inhibitor BAY 73-4506multi-kinase inhibitor XL092myleranN-803Nab-paclitaxel/danburstotug complex AP160nab-rapamycinNanoparticle Albumin-Bound RapamycinNanoparticle Albumin-Bound Sirolimusnatural killer cell stimulatory factor NM-IL-12NavelbineNavelbine ditartrateNCE401NemvaleukinNeoplatin NeosarNovoplatinumNovoTTF-100L(O)NSC 726189NT-I7NUV-655NVBNVP-BKM120NVP-KFA115OHPOK-1OMP-305B83OMP-313M32ONC-392oncolytic adenoviral vector-expressing anti-CD40 agonistic antibodyoncolytic herpes simplex virus-1 expressing anti-CTLA-4 antibody/CD40L/4-1BBL RP3oncolytic HSV-1-expressing IL-12 and anti-PD-1 antibody T3011oncolytic virus RP1ONO-4538ONT-380OpdivoPaclitaxel Albumin-Stabilized Nanoparticle FormulaPaclitaxel-loaded tumor penetrating microparticlespan-FGFR inhibitor ABSK-121-NXpan-RAF kinase inhibitor DAY101pan-RAF kinase inhibitor LXH254ParaplatinPARP inhibitor BGB-290PARP/Tankyrase inhibitor 2X-121PCI-24781PD-0325901PD0332991PD-0332991PD272PEG-PEI-cholesterol lipopolymer-encased IL-12 DNA plasmid vector GEN-1Pegylated Liposomal Doxorubicin Hydrochloridepegylated recombinant IL-2 variant THOR-707Pemetrexed disodiumPeposertibPerjetapertuzumab, trastuzumab, and hyaluronidase-zzxfPF-02341066PF-04554878PF-05212384PF-06463922PF-07901801PGE2 receptor antagonist INV-1120PH20 hyaluronidase-expressing adenovirus VCN-01phIL-12-005/PPCphosphoinositide 3-Kinase inhibitor BYL719PI3K alpha inhibitor MLN1117PI3K inhibitor BAY 80-6946PI3K inhibitor BYL719PI3K inhibitor GDC-0084PiqrayPKI-587PlacisPlaquenilPlatamine Platiblastin Platiblastin-S Platinex PlatinolPlatiranPlatistinPlatosinPLX4032Pol I inhibitor CX5461polyamine transport inhibitor AMXT-1501 dicapratePraxelpressurized intraperitoneal aerosol chemotherapyPrexasertibPRO1184Procytoxprostaglandin E2 EP4 receptor inhibitor E7046protein-engineered interleukin-2 XTX202PS-341PTPN11 inhibitor RMC-4630PXD101RAD001RadiotherapyRaf Kinase Inhibitor LGX818Raf/MEK dual kinase inhibitor RO5126766RapamuneRapamycinRAS inhibitor RMC-6236Ras-selective tri-complex inhibitor RMC-6236RC48-ADCRecentinrecombinant human IL-7-hybrid Fc NT-I7recombinant interleukin-12REGN2810REGN4018RELARET inhibitor EP0031RET kinase inhibitor LOXO-292RetevmoRG6114RG7440RG7446RG7601RG7666rhuMAb2C4ribocytokine IL-7 BNT152RiometRLI 15RLY-1971RMC 9805RMI-71782RNA Pol I inhibitor CX5461RNA transcription modulator AU-409Ro 24-7472RO5126766RO5185426RO7092284RozlytrekRP-3500RP-6306RTK inhibitor TKI258RXDX-101SalMet-VecSalmonella enterica serotype typhimurium expressing L-methioninase SGN1samarium Sm 153-DOTMPSAR442720SCH 900475SEA-TGTselective estrogen receptor downregulator GDC-9545SendoxanSHP2 inhibitor RMC-4630SHP2 inhibitor TNO155Smac mimetic BGB-24714Smac Mimetic TL32711SNDX-275SNDX-6352SO-C101SOT101SotorasibSPEAR T-cell ADP-A2M4CD8SprycelSRF813StavzorStivargaSTRO-002Sunitinib malatesuperagonist interleukin-15:interleukin-15 receptor alphaSu/Fc fusion complex N-803SutentSyklofosfamidTAB-001TAB004TAB006TAK-117TAK-580Talazoparib Tosylate TalzennaTarcevaTAS-120TasignaTaxolTaxol KonzentratTaxotereTazverikTC-210 T cellsTC-210 TruC-T cellsTCApFT-DM1T-DxdTecentriqTemodalTemodarTH 3424TH1902THOR-707TIC10TicilimumabTILT-123TJ033721TJ107TJ-L14BTL32711TMT212TNFalpha/IL-2-encoding oncolytic adenovirus TILT-123TOPOToposarToriselTPX-0005trastuzumab-DM1trastuzumab-MCC-DM1trastuzumab-MCC-DM1 antibody-drug conjugatetrastuzumab-MCC-DM1 immunoconjugateTRC102triptolide analogueTrk inhibitor LOXO-101TrkA inhibitor VMD-928TrkA/B/C/ROS1/ALK tyrosine kinase inhibitor RXDX-101TrodelvyTSR-042TTI-622tumor-cells apoptosis factor hormone-peptideTXLTykerbValproate VaniqaVAXINIAVE-822VebreltinibVelcadeVePesidVerzenioVinorelbine ditartrateVinorelbine tartrateViraceptVitrakviVNBVotrientVS-6063VS-6766VX-970WT1-targeted IL-2-based fusion protein CUE-102XalkoriXelodaXL184XL518XmAb20717XmAb717YervoyZD9238ZejulaZelborafZEN003694ZN-c3ZortressZW25Zytoxan Tumor Genomic Alteration: selectABL1AKT1AKT2AKT2 AMPAKT3ALKALK AMPARID1AATMATRATRXAXLBAP1BARD1Bcr-ablBLMBRAFBRAF V600BRAF V600EBRIP1CCND1 AMPCCND2 AMPCCND3 AMPCD274 (PD-L1)CCNE1 AMPCDK12CDK4 AMPCDK6 AMPCDKN2ACDKN2BCHEK1CHEK2cKITCREBBPCSF1RCTNNB1DDR2EGFR EGFR AMPEIF1AXEMSY AMPEP300EPHA2ERBB2 (aka HER2)ERBB2 AMPERBB3 AMPERBB3 (aka HER3)ERBB4 (aka HER4)ERCC1ERCC2FAM175AFANCA FANCA AMPFANCC FANCC AMPFANCD2 FANCD2 AMPFANCE FANCE AMPFANCFFANCGFANCLFANCMFBXW7FGFFGFR1 FGFR1 AMPFGFR2 FGFR2 AMPFGFR3 FGFR3 AMPFGFR4FGFR4 AMPFLT3FYNGNA11GNAQHRASIDH1IDH2KDRKDR AMPKEAP1KITKIT AMPKRAS KRAS AMPLCKMAP2K1MAP2K2LYNMET MDM4MDM2MET AMPMLH1MLL2MRE11AMSH2MSH6mTORMTAPMYC AMPMYCL AMPMYCN AMPNBNNF1NF2NRASNFE2L2NRG1NTRK1NTRK2NTRK3PALB2PARP1PARP2PDGFRPDGFRAPDGFRA AMPPDGFRBPIK3CA PIK3CA AMPPIK3CB AMPPIK3CB PIK3R1PMS2POLD1POLEPOLQPRKDCPPP2R1APPP2R2APTCH1PTENRAD50RAD51RAD51BRAD51CRAD51DRAD52RB1RAD54LRAF1RETRNF43ROS1RSPOSETD2SLX4SF3B1SMARCA4SMARCB1SMOSRCSRSF2STK11TIPARP AMPTORC1TORC2TRKTP53TSC1TSC2VEGFRU2AF1WRNXRCCYES1ZRSR2 Return only trials with results Include all Phase 1 trials (i.e., dose-finding as well as expansion) Criteria Arm: All All12345 Matching Trials Save Trials For more detailed information please click on the clinical trial number and you will be taken to the clinicaltrials.gov website. For a key to the icons and text used in the Results column, please click here. To learn more about our trial annotation process, results assignments, and the criteria used to highlight drugs with promising results, please click here. Clinical Trial Phase Eligible Participant Official Title Location Drugs in Trial Results NCT03735589I/IINewly diagnosed stage II-IV ovarian cancer that responded to first-line platinum therapyA Phase I/IIa Safety and Immunologic Efficacy Trial of Intraperitoneal Induction of CTLs Combined With Alpha-Dendritic Cell Vaccine for Primary Ovarian CancerNYView Drugs Drug(s) in Trial Other Drug Names Main Known Action Drug Status Alpha-DC1 vaccineImmune response against tumor-associated antigensClinical TrialsAutologous nCTLsAutologous Natural Killer Cell-like nCTLs, autologous natural killer-like cytotoxic lymphocytes, autologous aDC1-induced CTLsAnti-tumor immune responseClinical Trials NCT03832855IAdvanced HER3+ tumors with complete response after surgery and chemotherapyAssessing the Immunogenicity of pING-hHER3FL in Patients With Resected MalignanciesNCView Drugs Drug(s) in Trial Other Drug Names Main Known Action Drug Status pING-hHER3FLimmune response against cancer expressing ERBB3(HER3)Clinical Trials If you have any questions or would like help with your search, please call us at: 858-657-0282 or email us at patientsupport@clearityfoundation.org. × If you have any questions or would like help with your search, please call us at: 858-657-0282 or email us at patientsupport@clearityfoundation.org. × Results for ovarian cancer patients in the same or similar trial Promising results for ovarian cancer patients in the same or similar trial Results for a small number of ovarian cancer patients in the same or similar trial Promising results for a small number of ovarian cancer patients in the same or similar trial Results for patients with other cancer types in the same trial View Results Results for ovarian cancer patients in a different trial with same or similar drugs View Results Promising results for ovarian cancer patients in a different trial with same or similar drugs View Results Results for patients with other cancer types